← Back to front page
United States · Platforms & data · The Motley Fool

Trulieve Was the First U.S. Pure-Play Cannabis Stock on the NYSE. Here's Which Stock Could Be Next.

Published by The Motley Fool · United States 29 min ago
Trulieve Was the First U.S. Pure-Play Cannabis Stock on the NYSE. Here's Which Stock Could Be Next.
Trulieve Was the First U.S. Pure-Play Cannabis Stock on the NYSE. Here's Which Stock Could Be Next. · The Motley Fool

Detailed summary

Another cannabis company has rising revenue, strengthening its case for an exchange listing.

Trulieve Cannabis (TRLV -6.69%) became the first U.S. cannabis operator to list on the New York Stock Exchange on June 10 after a major change in federal marijuana policy. With that, the company accomplished something U.S. cannabis operators had been trying to do for years. And now, attention is turning to which company could follow.

One potential candidate is Green Thumb Industries (GTBIF -1.85%), one of the country's largest cannabis operators. It definitely has the revenue, cash flow, and financial resources to make a compelling case for a major U.S. exchange listing. Still, regulatory obstacles remain, and the company hasn't announced an approved uplisting.

Trulieve's NYSE debut followed the federal government's April 2026 decision to move state-licensed medical marijuana into Schedule III, allowing sales of drugs with potential therapuetic value as opposed to Schedule I, which bars sales of dangerous substances. That change created an opportunity for medical cannabis companies to access major U.S. exchanges.

However, Trulieve also had to restructure its business, separating its medical operations from businesses serving both recreational and medical customers. Recreational marijuana remains federally prohibited, which creates complications for other multi-state operators.

Green Thumb's latest financial results provide a strong argument for its consideration. In Q3, the company reported revenue of $324.4 million, representing an increase of 11% from the previous year. Normalized earnings before interest, taxes, depreciation, and amortization (EBITDA) reached $89.4 million, representing a margin of 27.6%, and the company generated $58.3 million in operating cash flow during the quarter.

Its balance sheet is another advantage. Green Thumb ended September with $316 million in cash and $277.3 million in total debt, including $177 million in senior debt. Management has also been returning capital to shareholders.

Green Thumb still faces significant obstacles.

To clarify…

Opening of the article, excerpted from The Motley Fool. To read the rest, open the article on the publisher's site.

Read the full article on The Motley Fool Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fool.com)

Also worth reading